Ambulation-evaluable patients.
|
|
|
|
||
Re: Sarepta's Briefing Docs for Adcom - Mendell's baseline chart
From Mendell's paper "Patient 009 walked 346m at baseline and (010) walked 261m at baseline, From the above chart comparing the other two 30mg boys, one might conclude one walked 372 and 442 at baseline, and none of those baseline numbers matches Sarepta's recently submitted numbers in their baseline numbers to the public. Baseline Yr. 4 Age 30mg/placebo 007 374 197 11.67 008 346 55 14.2 50mg/placebo 005 374 143 11.7 013 400 230 14.3 30mg 002 416 349 12.7 006 355 332 14.2 009 330 0 13.9 010 256 0 13.9 50mg 003 366 192 11.0 004 389 221 12.5 012 351 237 14.6 015 401 400 13.3 |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
12419 | Re: Anyone ask Kaye why Sarepta's baseline numbers differ from Mendell's peer reviewed paper's baseline numbers for 6mwt??? | pineappleguava | 0 | 3/23/2017 12:20:14 PM |